70 odd million shares on issue so around $2 - $2.80.
That said, the company will have to raise funds to continue through and with their Phase 2, so.....
The point I was trying to make is that should Phase 1 be successful, in my opinion, we are grossly undervalued.
Time will tell if I'm correct!
Ann: Maximum Tolerated Dose Successfully Established in Studies, page-11
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
76.0¢ |
Change
0.010(1.33%) |
Mkt cap ! $97.35M | |||
| Open | High | Low | Value | Volume |
| 76.0¢ | 77.5¢ | 75.0¢ | $154.6K | 203.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7573 | 76.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 76.5¢ | 1327 | 1 |
View Market Depth
| Last trade - 14.55pm 11/11/2024 (20 minute delay) ? |
| AGN (ASX) Chart |